Spruce Biosciences, Inc.
Spruce Biosciences, Inc. (SPRB) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
sprb · stock forecast · 11 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Buy
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$283
Consensus
$191
+287.3% upside
Low
$140
Median: $150 · Last Close: $49.32
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$191.00
287.3% upside
High Target
$283
473.8%
Low Target
$140
183.9%
Current Price
$49.32
as of today
Based on analyst price targets, the SPRB stock price prediction for the next 12 months ranges from $140 to $283. The consensus SPRB price forecast of $191.00 implies 287.3% upside from the current price of $49.32.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $48.29 | ↓ 2.08% |
1-day model range: $47.46–$49.12. Peak: $49.12 (-2.08%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · SPRB · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-14 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-10 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-02-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-03 | Leerink Partners | Upgrade ↑ | Market Perform→Outperform |
| 2025-11-11 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-10-28 | JMP Securities | Upgrade ↑ | Market Perform→Market Outperform |
| 2025-10-21 | Leerink Partners | Maintains | Market Perform→Market Perform |
| 2025-04-16 | RBC Capital | Maintains | Sector Perform→Sector Perform |
Wall Street analysts have recently issued updated ratings on Spruce Biosciences, Inc. (SPRB) stock. Of the recent 52 rating actions, 3 were upgrades and 9 were downgrades. 11 analysts currently cover SPRB.
Analyst Recommendation Trends
SPRB analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$54M
↑ 160.6% YoY
Revenue Next Year
$76M
↑ 41.6% YoY
EPS This Year
$-22.85
EPS Next Year
$-3.87
↓ 83.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast SPRB EPS of $-22.85 for the current fiscal year, based on estimates from 3 analysts. The SPRB revenue forecast is $54M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The SPRB stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SPRB price target is $191.00 (+287.3% upside), with an analyst consensus of Buy.
The SPRB short-term stock prediction for tomorrow is $48.29 (-2.08%).
Spruce Biosciences, Inc. trades on NASDAQ under the ticker SPRB. The SPRB stock outlook for 2027 is broadly positive, supported by a Buy consensus among 55% of covering analysts.
Frequently asked questions
SPRB forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month SPRB price target is $191.00, with a high forecast of $283.00 and a low of $140.00. The median price target is shown in the chart above when available. This implies +287.3% potential upside from the current price of $49.32.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.